Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to validate prospectively the predictive score of late results about a diverse population recruited in France and to evaluate the contribution in predicting the outcome of the PMC scanner to study the mitral calcium score and the location of the calcifications.


Clinical Trial Description

This is a multicenter prospective observational study conducted in French medico-surgical sites. The Percutaneous Mitral Commissurotomy (PMC) is the standard treatment for Mitral stenosis (MS) in patients with rheumatic favorable characteristics. In Western countries the MS reaches older patients with less favorable characteristics, including the presence of mitral calcifications. Calcifications are a factor of poor outcome of the PMC. The scanner appears as a useful examination for their study but is not carried out systematically. The prediction of late results of the PMC is particularly important in patients with non-ideal characteristics which form a particularly heterogeneous population. A score of late results of the PMC on the wider western series was recently released but has not to date received external validation. In this score, prediction results was multifactorial, with a consideration of paramount clinical factors, but also a prognostic significance of mitral calcifications. The validation of predictive score of late results of the PMC, with the analysis of calcifications, would better select patients who may best benefit from PMC and those for which the surgical management is preferred. The aim of this study is to validate an external sample predictive score of the event-free survival in patients who have had a good immediate result of the PMC. This study, purely observational, does not create any special procedure outside the patient's usual care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02783248
Study type Observational
Source French Cardiology Society
Contact
Status Completed
Phase
Start date June 2016
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06167213 - ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral N/A
Completed NCT02188862 - Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region N/A
Recruiting NCT04045093 - Dabigatran for Mitral Stenosis Atrial Fibrillation Phase 4
Recruiting NCT05625607 - Polish Transcatheter Transfemoral Mitral Valve-in-Valve Implantation (Mitral ViV) Registry
Not yet recruiting NCT06067815 - Assessment of Right Ventricular Function in Patients With Severe Mitral Stenosis Before and After Balloon Mitral Valvuloplasty
Completed NCT01022463 - Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm Phase 3
Terminated NCT03926156 - RIvoraxaban in Mitral Stenosis Phase 3
Not yet recruiting NCT06377449 - Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients N/A
Recruiting NCT04408430 - The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves). N/A
Active, not recruiting NCT06191718 - Clinical Investigation for the Foldax Tria Mitral Valve- India N/A
Recruiting NCT03991910 - The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients Phase 3
Recruiting NCT05925335 - The China Mviv Registry N/A
Not yet recruiting NCT06340997 - Impact of Percutaneous Transvenous Mitral Commissurotomy on The Left Atrial Appendage Function in Patients With Mitral Stenosis. N/A
Completed NCT02502448 - Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery N/A
Completed NCT04527367 - Epidemiology and Long-term Outcome of Patients With VHD
Active, not recruiting NCT05526560 - Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
Completed NCT06371222 - Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm Phase 4
Completed NCT02831270 - Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery N/A
Recruiting NCT01270750 - Bosentan for Severe Mitral Valve Dysfunction Phase 1/Phase 2
Active, not recruiting NCT01757665 - ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) N/A